ArticleMolecular cancer2013

Cell cycle-dependent activity of the novel dual PI3K-MTORC1/2 inhibitor NVP-BGT226 in acute leukemia.

Kerstin Maria Kampa-Schittenhelm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.